Literature DB >> 21549827

Macrophages, rather than T and B cells are principal immunostimulatory target cells of Lycium barbarum L. polysaccharide LBPF4-OL.

Xiao Rui Zhang1, Wen Xia Zhou, Yong Xiang Zhang, Chun Hui Qi, Huanga Yan, Zhong Fu Wang, Bo Wang.   

Abstract

AIM OF THE STUDY: Lycium barbarum L. is a renowned Yin strengthening agent in traditional Chinese medicine. Lycium barbarum L. polysaccharide-protein complex is well-known for its immunoregulatory and antitumor effects. LBPF4-OL is the glycan part of Lycium barbarum L. polysaccharide-protein complex fraction 4 (LBPF4). LBPF4-OL's active contribution in LBPF4 is still blank. In the study, we enrich the polysaccharide part of Lycium barbarum L. polysaccharide-protein complex, and investigate its immunostimulatory effects on mouse spleen cells, T cells, B cells and macrophages.
MATERIALS AND METHODS: Balb/C mice were used in vitro and in vivo studies. In in vitro study, lymphocyte proliferations were analyzed with (3)H-TdR incorporation method. Miltenyi MicroBeads were used in the purification of lymphocytes. Activation of T and B cells was analyzed by flow cytometry. In order to obtain the peritoneal macrophages, mice were injected i.p. with 1mL of sodium thioglycollate 3 days prior to killing. Spleen cells were stimulated with LBPF4-OL and cytokine concentrations in the supernatants were determined by multiplex bead analysis. In in vivo study, mice were injected i.p. with 1 mL of normal saline or 100 μg/mL LBPF4-OL daily for 6 days. Peritoneal macrophage functions were analyzed by enzyme-linked immunosorbent assay and flow cytometry assay.
RESULTS: Spleen cells and lymphocyte proliferation assay indicated that LBPF4-OL markedly induced the spleen cell proliferation, but could not induce proliferation of purified T and B lymphocytes. Further research revealed that B cell proliferation took place in the presence of activated macrophages or LPS. Multiplex bead analysis showed that LBPF4-OL can obviously induce IL-6, IL-8, IL-10 and TNF-α production of the spleen cells in a concentration-dependent manner. Flow cytometric analysis showed that LBPF4-OL (i.p.) prompts CD86 and MHC-II molecules expression on macrophages. ELISA assay showed that LBPF4-OL can greatly strengthen macrophage releasing of TNF-α and IL-1β.
CONCLUSION: These results suggested that glycan LBPF4-OL plays an important role in the immunopharmacological activity of Lycium barbarum L. polysaccharide-protein complex, and primary mouse macrophages, rather than T and B cells, are the principal target cells of it.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21549827     DOI: 10.1016/j.jep.2011.04.054

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  10 in total

1.  Sulfated modification promotes the immunomodulatory bioactivities of Lyciumbarbarum polysaccharides in vitro.

Authors:  Junmin Wang; Beilei Ge; Chunyan Du; Jingli Xue; Yuwei Zhuang; Kun Xue
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Lycium barbarum polysaccharide fraction associated with photobiomodulation protects from epithelium thickness and collagen fragmentation in a model of cutaneous photodamage.

Authors:  Lia Mara Grosso Neves; Carla Roberta Tim; Elaine Medeiros Floriano; Lucimar Retto da Silva de Avó; João Batista Fernandes; Nivaldo Antonio Parizotto; Marcia Regina Cominetti
Journal:  Lasers Med Sci       Date:  2020-08-22       Impact factor: 3.161

Review 3.  An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides.

Authors:  Jiang Cheng; Zhi-Wei Zhou; Hui-Ping Sheng; Lan-Jie He; Xue-Wen Fan; Zhi-Xu He; Tao Sun; Xueji Zhang; Ruan Jin Zhao; Ling Gu; Chuanhai Cao; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-12-17       Impact factor: 4.162

4.  Hypoglycemic Effects of Lycium barbarum Polysaccharide in Type 2 Diabetes Mellitus Mice via Modulating Gut Microbiota.

Authors:  Qingyu Ma; Ruohan Zhai; Xiaoqing Xie; Tao Chen; Ziqi Zhang; Huicui Liu; Chenxi Nie; Xiaojin Yuan; Aobai Tu; Baoming Tian; Min Zhang; Zhifei Chen; Juxiu Li
Journal:  Front Nutr       Date:  2022-06-30

5.  Emodin induces human T cell apoptosis in vitro by ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction.

Authors:  Kai Qu; Nai-ying Shen; Xin-sen Xu; Hai-bo Su; Ji-chao Wei; Ming-hui Tai; Fan-di Meng; Lei Zhou; Yue-lang Zhang; Chang Liu
Journal:  Acta Pharmacol Sin       Date:  2013-07-01       Impact factor: 6.150

6.  Application of serum pharmacology in evaluating the antitumor effect of Fuzheng Yiliu Decoction from Chinese medicine.

Authors:  Xu-zheng Chen; Zhi-yun Cao; Lian-ming Liao; Zhi-zhen Liu; Jian Du
Journal:  Chin J Integr Med       Date:  2013-11-16       Impact factor: 1.978

7.  Developing Phytocompounds from Medicinal Plants as Immunomodulators.

Authors:  Chih-Chun Wen; Hui-Ming Chen; Ning-Sun Yang
Journal:  Adv Bot Res       Date:  2012-06-19       Impact factor: 2.175

8.  Diversity and spatiotemporal dynamics of fungal communities in the rhizosphere soil of Lycium barbarum L.: a new insight into the mechanism of geoherb formation.

Authors:  Yuekun Li; Kaili Chen; Siyang Liu; Xiaojie Liang; Yajun Wang; Xuan Zhou; Yue Yin; Youlong Cao; Wei An; Ken Qin; Yanfei Sun
Journal:  Arch Microbiol       Date:  2022-02-26       Impact factor: 2.552

9.  Efficacy of Pretreatment with Lycium barbarum Polysaccharide in Various Doses in Influencing Splenic Immunity and Prognosis of Sepsis in Rats.

Authors:  Huan Ding; Ping Yang; Xue-Hong Zhang; Yu-Jie Ma
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-04       Impact factor: 2.650

Review 10.  Lycium Barbarum: A Traditional Chinese Herb and A Promising Anti-Aging Agent.

Authors:  Yanjie Gao; Yifo Wei; Yuqing Wang; Fang Gao; Zhigang Chen
Journal:  Aging Dis       Date:  2017-12-01       Impact factor: 6.745

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.